Ki-67 Cancer Research Results
Ki-67, Ki-67 protein: Click to Expand ⟱
| Source: |
| Type: proliferation marker |
A high Ki-67 proliferation index means many cells are dividing quickly and that the cancer is likely to grow and spread.
Markers of proliferation index (Ki-67)
• Ki-67 serves primarily as a proliferation marker: higher levels are generally indicative of aggressive disease and poorer outcomes across many cancer types.
• While Ki-67 itself is not considered a driver of tumorigenesis, its expression mirrors the high proliferative activity associated with protumoral behavior.
• It is widely used in clinical practice to aid in tumor grading, prognostication, and treatment planning.
|
NSCLC, Non-small Cell Lung Cancer: Click to Expand ⟱
Non-small Cell Lung Cancer
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
NSCLC, |
A549 |
|
|
|
- |
in-vitro, |
NSCLC, |
H1299 |
|
|
|
TumCP↓, Ki-67↓, GPx4↓, ACSL4↑, Iron↑, MDA↑, ROS↑, Ferroptosis↑, eff↑, NRF2↑, HO-1↑,
| - |
in-vitro, |
NSCLC, |
Calu-1 |
|
|
|
TumCP↓, PCNA↓, Ki-67↓, MCM2↓, Bcl-2↓, BAX↑, cl‑Casp3↑, TumCMig↓, TumCI↓, Hif1a↓, VEGF↓,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Ferroptosis↑, 1, GPx4↓, 1, HO-1↑, 1, Iron↑, 1, MDA↑, 1, NRF2↑, 1, ROS↑, 1,
Core Metabolism/Glycolysis ⓘ
ACSL4↑, 1,
Cell Death ⓘ
BAX↑, 1, Bcl-2↓, 1, cl‑Casp3↑, 1, Ferroptosis↑, 1,
DNA Damage & Repair ⓘ
PCNA↓, 1,
Proliferation, Differentiation & Cell State ⓘ
MCM2↓, 1,
Migration ⓘ
Ki-67↓, 2, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 2,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1, VEGF↓, 1,
Drug Metabolism & Resistance ⓘ
eff↑, 1,
Clinical Biomarkers ⓘ
Ki-67↓, 2,
Total Targets: 22
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: Ki-67, Ki-67 protein
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:19 Cells:% prod#:% Target#:425 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page